当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2024-04-25 , DOI: 10.1056/nejmoa2313812 Yongxian Hu 1 , Mingming Zhang 1 , Tingting Yang 1 , Zhuomao Mo 1 , Guoqing Wei 1 , Ruirui Jing 1 , Houli Zhao 1 , Rongrong Chen 1 , Cheng Zu 1 , Tianning Gu 1 , Pingnan Xiao 1 , Ruimin Hong 1 , Jingjing Feng 1 , Shan Fu 1 , Delin Kong 1 , Huijun Xu 1 , Jiazhen Cui 1 , Simao Huang 1 , Bin Liang 1 , Xiaolin Yuan 1 , Qu Cui 1 , Hongshan Guo 1 , Yunxian Yu 1 , Youqin Feng 1 , Chunxiang Jin 1 , Jiangtao Ren 1 , Alex H. Chang 1 , Dongrui Wang 1 , He Huang 1
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2024-04-25 , DOI: 10.1056/nejmoa2313812 Yongxian Hu 1 , Mingming Zhang 1 , Tingting Yang 1 , Zhuomao Mo 1 , Guoqing Wei 1 , Ruirui Jing 1 , Houli Zhao 1 , Rongrong Chen 1 , Cheng Zu 1 , Tianning Gu 1 , Pingnan Xiao 1 , Ruimin Hong 1 , Jingjing Feng 1 , Shan Fu 1 , Delin Kong 1 , Huijun Xu 1 , Jiazhen Cui 1 , Simao Huang 1 , Bin Liang 1 , Xiaolin Yuan 1 , Qu Cui 1 , Hongshan Guo 1 , Yunxian Yu 1 , Youqin Feng 1 , Chunxiang Jin 1 , Jiangtao Ren 1 , Alex H. Chang 1 , Dongrui Wang 1 , He Huang 1
Affiliation
Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation (HSC...
中文翻译：
无 GVHD 预防的序贯 CD7 CAR T 细胞治疗和同种异体 HSCT
复发性或难治性血液癌症患者的预后较差。嵌合抗原受体 (CAR) T 细胞疗法作为同种异体造血干细胞移植 (HSC...
更新日期：2024-04-25
中文翻译：
无 GVHD 预防的序贯 CD7 CAR T 细胞治疗和同种异体 HSCT
复发性或难治性血液癌症患者的预后较差。嵌合抗原受体 (CAR) T 细胞疗法作为同种异体造血干细胞移植 (HSC...
京公网安备 11010802027423号